These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 9692663)
1. Intravaginal morphine: an alternative route of administration. Ostrop NJ; Lamb J; Reid G Pharmacotherapy; 1998; 18(4):863-5. PubMed ID: 9692663 [TBL] [Abstract][Full Text] [Related]
2. Long-term rectal administration of high-dose sustained-release morphine tablets. Walsh D; Tropiano PS Support Care Cancer; 2002 Nov; 10(8):653-5. PubMed ID: 12436225 [TBL] [Abstract][Full Text] [Related]
3. [Effects of sustained release morphine hydrochloride tablets in management of cancer pain: a survey of 567 patients]. Yu SY; Qiu H; Ma ZS; Chen J; Zhang Y; Chen LZ; Wang DL; Ma ZY Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(6):450-5. PubMed ID: 15061959 [TBL] [Abstract][Full Text] [Related]
4. [Nociceptive cancer pain in adult patients: statement about guidelines related to the use of antinociceptive medicine]. Binhas M; Krakowski I; Marty J Ann Fr Anesth Reanim; 2007 Jun; 26(6):502-15. PubMed ID: 17560755 [TBL] [Abstract][Full Text] [Related]
5. The bioavailability of morphine in controlled-release 30-mg tablets per rectum compared with immediate-release 30-mg rectal suppositories and controlled-release 30-mg oral tablets. Kaiko RF; Fitzmartin RD; Thomas GB; Goldenheim PD Pharmacotherapy; 1992; 12(2):107-13. PubMed ID: 1570227 [TBL] [Abstract][Full Text] [Related]
6. [Treatment of pain in cancer with systemically administered opioids]. Enting RH; van der Rijt CC; Wilms EB; Lieverse PJ; de Wit R; Smitt PA Ned Tijdschr Geneeskd; 2001 May; 145(20):950-4. PubMed ID: 11396259 [TBL] [Abstract][Full Text] [Related]
7. Oral versus intravenous opioid dosing for the initial treatment of acute musculoskeletal pain in the emergency department. Miner JR; Moore J; Gray RO; Skinner L; Biros MH Acad Emerg Med; 2008 Dec; 15(12):1234-40. PubMed ID: 18945240 [TBL] [Abstract][Full Text] [Related]
9. Parenteral morphine prescribing patterns among inpatients with pain from advanced cancer: a prospective survey of intravenous and subcutaneous use. Walsh D; Perin ML; McIver B Am J Hosp Palliat Care; 2006; 23(5):353-9. PubMed ID: 17060302 [TBL] [Abstract][Full Text] [Related]
10. Continuous morphine infusions for cancer pain in resource-scarce environments: comparison of the subcutaneous and intravenous routes of administration. Koshy RC; Kuriakose R; Sebastian P; Koshy C J Pain Palliat Care Pharmacother; 2005; 19(1):27-33. PubMed ID: 15814512 [TBL] [Abstract][Full Text] [Related]
11. Analgesic efficacy and safety of morphine-chitosan nasal solution in patients with moderate to severe pain following orthopedic surgery. Stoker DG; Reber KR; Waltzman LS; Ernst C; Hamilton D; Gawarecki D; Mermelstein F; McNicol E; Wright C; Carr DB Pain Med; 2008; 9(1):3-12. PubMed ID: 18254761 [TBL] [Abstract][Full Text] [Related]
12. Safety and effectiveness of intravenous morphine for episodic (breakthrough) pain using a fixed ratio with the oral daily morphine dose. Mercadante S; Villari P; Ferrera P; Bianchi M; Casuccio A J Pain Symptom Manage; 2004 Apr; 27(4):352-9. PubMed ID: 15050663 [TBL] [Abstract][Full Text] [Related]
14. Oral oxycodone: new preparation. No better than oral morphine. Prescrire Int; 2003 Jun; 12(65):83-4. PubMed ID: 12825566 [TBL] [Abstract][Full Text] [Related]
15. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626 [TBL] [Abstract][Full Text] [Related]
16. Intrathecal treatment in cancer patients unresponsive to multiple trials of systemic opioids. Mercadante S; Intravaia G; Villari P; Ferrera P; Riina S; David F; Mangione S Clin J Pain; 2007; 23(9):793-8. PubMed ID: 18075407 [TBL] [Abstract][Full Text] [Related]
17. [Parenteral opioids in end-of-life care in cancer patients]. Hattori S; Kimura N; Takatani J; Noguchi T Gan To Kagaku Ryoho; 2005 Feb; 32(2):161-6. PubMed ID: 15751626 [TBL] [Abstract][Full Text] [Related]
18. Outcomes after intravenous opioids in emergency patients: a prospective cohort analysis. O'Connor AB; Zwemer FL; Hays DP; Feng C Acad Emerg Med; 2009 Jun; 16(6):477-87. PubMed ID: 19426295 [TBL] [Abstract][Full Text] [Related]
19. Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial. van Beers EJ; van Tuijn CF; Nieuwkerk PT; Friederich PW; Vranken JH; Biemond BJ Am J Hematol; 2007 Nov; 82(11):955-60. PubMed ID: 17617790 [TBL] [Abstract][Full Text] [Related]
20. A randomized clinical trial of oral transmucosal fentanyl citrate versus intravenous morphine sulfate for initial control of pain in children with extremity injuries. Mahar PJ; Rana JA; Kennedy CS; Christopher NC Pediatr Emerg Care; 2007 Aug; 23(8):544-8. PubMed ID: 17726413 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]